Aug 09, 2016 22:00 pm UTC| Business
SAN JOSE, Calif., Aug. 09, 2016 -- Firsthand Technology Value Fund, Inc. (NASDAQ:SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, announced today its...
Home BancShares, Inc. Chairman Highlighted Among Ten Arkansas Business Icons
Aug 09, 2016 21:45 pm UTC| Business
CONWAY, Ark., Aug. 09, 2016 -- Home BancShares, Inc. (NASDAQ:HOMB), parent company of Centennial Bank, announces that its Chairman, John W. Allison, was highlighted in the Arkansas Business article “Ten Arkansas...
Fortress Biotech Reports Second Quarter 2016 Financial Results and Recent Corporate Highlights
Aug 09, 2016 21:43 pm UTC| Business
NEW YORK, Aug. 09, 2016 -- Fortress Biotech, Inc. (NASDAQ:FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today...
Aug 09, 2016 21:37 pm UTC| Business
NEW YORK, Aug. 09, 2016 -- At the end of the settlement date of July 29, 2016, short interest in 2,335 Nasdaq Global MarketSM securities totaled 7,662,477,758 shares compared with 7,875,755,447 shares in 2,329 Global...
James Lally Named President of Enterprise Financial
Aug 09, 2016 21:33 pm UTC| Business
ST. LOUIS, Aug. 09, 2016 -- As part of an orderly management succession and transition plan, Enterprise Financial Services Corp (NASDAQ:EFSC) announced that James B. Lally, 48, has been named president of the company....
IASIS Healthcare to Broadcast Its Fiscal Third Quarter 2016 Conference Call Live on the Internet
Aug 09, 2016 21:30 pm UTC| Business
FRANKLIN, Tenn., Aug. 09, 2016 -- IASIS Healthcare® LLC (“IASIS”) today announced that it will provide an online Web simulcast of its fiscal third quarter 2016 conference call on Monday, August 15, 2016. The Company...
Axsome Therapeutics Reports Second Quarter 2016 Financial Results
Aug 09, 2016 21:30 pm UTC| Business
NEW YORK, Aug. 09, 2016 -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today reported...